Treatment of Post-Traumatic Stress Disorder (PTSD)
Trauma-focused psychotherapies are the recommended first-line treatment for PTSD, with medications such as sertraline and paroxetine serving as second-line options or adjuncts to therapy. 1
First-Line Treatment: Trauma-Focused Psychotherapies
- Trauma-focused psychotherapies that directly address the traumatic event are considered the most effective treatments for PTSD and should be offered as first-line treatment 1
- Evidence-based trauma-focused psychotherapies include:
Phase-Based Approach for Complex PTSD
- For complex PTSD (cPTSD), a phase-based approach is recommended by expert consensus 2:
- Phase I: Stabilization - focusing on safety, reducing self-regulation problems, and improving emotional competencies 2
- Phase II: Trauma processing - directly addressing and processing trauma memories 2
- Phase III: Reintegration - consolidating treatment gains and adapting to current life circumstances 2
Pharmacotherapy Options
- Two FDA-approved medications for PTSD:
- Pharmacotherapy should be considered when:
Special Considerations for Sleep Disturbances
- Sleep disturbances are common in PTSD and may require targeted treatment 5
- Prazosin is effective for PTSD-related sleep disturbance and nightmares 5
- Patients with PTSD should be evaluated for obstructive sleep apnea, which is common in this population 5
Treatment Algorithms and Decision-Making
Initial Treatment Decision:
For Complex PTSD:
For Partial Response:
Common Pitfalls and Caveats
- Psychological debriefing immediately after trauma is not recommended and may be harmful 2
- Benzodiazepines have not proven useful in controlled trials and may cause rebound effects upon discontinuation 7
- Relapse is common after medication discontinuation; longer-term treatment may be necessary 2, 3
- The distinction between PTSD and complex PTSD remains controversial, with some evidence suggesting differences in symptom severity rather than type 2
Emerging Treatments
- MDMA-assisted psychotherapy and other psychedelic treatments show promise but are not yet FDA-approved 1, 8
- Combining psychedelics with evidence-based psychotherapies may enhance treatment response 1, 8
- Other investigational approaches include neuropeptide Y, oxytocin, cannabinoids, and neuroactive steroids 8